A Study Of Stellate Ganglion Blockade With Liposomal Bupivacaine In Preventing Atrial Fibrillation After Isolated Coronary Artery Bypass Grafting Surgery
Effectiveness Of Liposomal Bupivacaine Stellate Ganglion Blockade In Preventing Atrial Fibrillation After Isolated Coronary Artery Bypass Grafting Surgery: A Randomized Placebo-Controlled Trial
The purpose of this study is assess the incidence of postoperative atrial fibrillation (POAF) within one week of surgery in patients who receive pre-surgical stellate ganglion blockade with liposomal bupivacaine, compared to those receiving a saline placebo, using continuous electrocardiographic monitoring via wearable ECG devices.
研究概览
研究类型
注册 (估计的)
阶段
- 第四阶段
联系人和位置
学习联系方式
- 姓名:Anesthesia Clinical Research Unit (ACRU) Study Team
- 电话号码:866-265-9263
- 邮箱:ripollsanz.juan@mayo.edu
学习地点
-
-
Minnesota
-
Rochester、Minnesota、美国、55905
- 招聘中
- Mayo Clinic in Rochester
-
接触:
- ACRU Study Team
- 电话号码:866-265-9263
-
首席研究员:
- Juan G. Ripoll Sanz, MD
-
副研究员:
- Erica Wittwer, MD,PhD
-
-
参与标准
资格标准
适合学习的年龄
接受健康志愿者
有资格学习的性别
描述
Inclusion Criteria:
- Adults aged ≥40 years scheduled to undergo isolated coronary artery bypass grafting will be eligible. Robotic CABG procedures are allowed.
- Cases will also remain eligible if, after the initial surgical listing, additional procedures-such as valvular interventions or septal myectomy-are performed, OR if CABG is listed as the primary intervention with other procedures noted as possible additional interventions.
- Cases will remain eligible if left atrial appendage ligation is concomitantly listed with the CABG.
Exclusion criteria:
- History of Permanent atrial fibrillation (paroxysmal, persistent or permanent),
- Mechanical circulatory support implant or explant
- Heart and/or lung transplant patients
- Active infection/sepsis
- Pre-operative anti-arrhythmic use (aside from beta-blockers).
- MAZE procedures, pulmonary vein isolation or cryotherapy will exclude patients if concomitantly listed with the CABG.
- Participant has a known allergy to adhesives or hydrogels.
- Participant has a visible skin injury or broken skin at the location for study device placement.
- Participant does not have the competency to wear the device for the prescribed patching period.
- Participant has a neuro-stimulator, as it may disrupt the quality of ECG data.
- Participants who are pregnant. In accordance with Mayo Clinic's standard cardiac surgery protocol, all women of childbearing potential undergo routine preoperative pregnancy testing. Pregnancy status will therefore be confirmed prior to enrollment. Any participant with a positive pregnancy test will be deemed ineligible and will not be enrolled in the study.
- Participants who lack the capacity to provide informed consent will not be approached or enrolled in this study.
学习计划
研究是如何设计的?
设计细节
- 主要用途:治疗
- 分配:随机化
- 介入模型:并行分配
- 屏蔽:双倍的
武器和干预
参与者组/臂 |
干预/治疗 |
|---|---|
|
实验性的:Stellate ganglion block using liposomal bupivacaine
10 mL of liposomal bupivacaine 133 mg (133 mg/10 ml or 1.33%) |
Patients undergoing isolated coronary artery bypass grafting will receive a stellate ganglion block using liposomal bupivacaine prior to surgery |
|
安慰剂比较:Sham block using saline placebo
10 mL of saline placebo injected in the plane of the right stellate ganglion |
Patients undergoing isolated coronary artery bypass grafting will receive a saline placebo injection to the stellate ganglion prior to surgery |
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Incidence of new-onset postoperative atrial fibrillation (POAF) within one week of isolated coronary artery bypass grafting (CABG) surgery
大体时间:1 week
|
Total number of patients to experience postoperative atrial fibrillation within one week of CABG surgery. |
1 week
|
次要结果测量
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Total duration of postoperative atrial fibrillation (POAF) episodes within the first postoperative week
大体时间:1 week
|
Duration of postoperative atrial fibrillation episodes will assessed via continuous ECG monitoring and reported in minutes |
1 week
|
|
Number of patients with successful stellate ganglion blockade
大体时间:1 week
|
Success rate of the stellate ganglion blockade is defined as a ≥1.0°C increase in ipsilateral hand skin temperature from baseline and/or a reduction in skin sympathetic nerve activity (SKNA) as measured by noninvasive surface recordings pre- and post-block. |
1 week
|
合作者和调查者
赞助
调查人员
- 首席研究员:Juan G. Ripoll Sanz, MD、Mayo Clinic
出版物和有用的链接
研究记录日期
研究主要日期
学习开始 (实际的)
初级完成 (估计的)
研究完成 (估计的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (实际的)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.